ZMC and WuXi Joint Quality Responsibility. 10.2.1 ZMC and WuXi shall be responsible for the Final Release of the Products for further manufacturing use, animal studies, or clinical distribution following joint review of the Disposition Packages provided by WuXi. ZMC and WuXi agree to reasonable review periods and completion of document requests.
Appears in 4 contracts
Samples: Co Development and License Agreement (Ambrx Biopharma Inc.), Co Development and License Agreement (Ambrx Biopharma Inc.), Development and License Agreement (Ambrx Inc)
